Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-19-029723)

Filing Details

Accession Number:: 0001144204-19-029723
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-04 16:22:02
Reporting Period:: 2019-05-31

Accepted Time:: 2019-06-04 16:22:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1386609	D Alan Weinstein	C/O Akorn, Inc. 1925 W. Field Court, Suite 300 Lake Forest IL 60045		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-31	50,000	$3.97	161,555	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,200	Indirect	By Spouse

Footnotes

Following the reported transaction, the amount of shares beneficially owned includes 46,610 unvested RSUs and 114,945 shares owned outright.